SCHEMBL6049346

SCHEMBL6049346

CC(C)(C)OC(=O)c1cc2cc(CCCCCc3cccc(O)c3)ccc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.47
CLK1 P49759 1/20 0.42
DYRK1A Q13627 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
PLA2G4A P47712 1/20 0.41
KDM4E B2RXH2 3/20 0.40
MGLL Q99685 1/20 0.40
FLT3 P36888 4/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ABL1 P00519 1/20 0.39
PDGFRB P09619 1/20 0.39
KIT P10721 1/20 0.39
BCR P11274 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
SRD5A2 P31213 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6049273 0.84 SRC (0.41) SRCCLK1DYRK1AKDM4EFLT3
SCHEMBL6139977 0.83 SMAD3 (0.58) SRCCLK1DYRK1AHDAC6PLA2G4A
SCHEMBL5795136 0.79 KDM4E (0.48) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL6049347 0.77 GABRA1 (0.44) HDAC6RAB9A
SCHEMBL6049345 0.74 HRH3 (0.39) SRCCLK1DYRK1AKDM4EFLT3
SCHEMBL832227 0.72 RAB9A (0.67) KDM4EFLT3ALDH1A1HPGDHSD17B10
SCHEMBL29496122 0.71 KDM4E (0.63) KDM4EFLT3ALDH1A1HPGDHSD17B10
SCHEMBL318243 0.71 KDM4E (0.63) KDM4EFLT3ALDH1A1HPGDHSD17B10
SCHEMBL5842585 0.71 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL6049301 0.71 NPC1 (0.48) KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264480-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same SUH YOUNG G 2006-11-23 US disclosed
US-20030203944-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same PACIFIC CORPORATION (KR) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264480-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same TRPV1, TRPA1, TRPV5 SRC 4554/4885CLK1 4205/4885DYRK1A 3454/4885
US-20030203944-A1 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same TRPV1, TRPA1, TRPV5 SRC 4554/4885CLK1 4205/4885DYRK1A 3454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.